Prof. Jiang received his medical degree from Shanghai Medical University in 1982. Between 1997 and 2000, he was selected by the Ministry of Health and sent to M.D. Anderson Cancer Center and other famous cancer center in the U.S as a visiting scholar. In 2005, he received his h-EMBA degree from Sun Yat-Sen University. He has been engaged in clinical practice of solid tumors for over 30 years, and has rich clinical experience in MDT treatment of various types of tumors (including chemotherapy, endocrine therapy, biotherapy and immunotherapy, etc.). He won the "National Outstanding Scientific and Technological Worker) in 2014.

Prof. Jiang returned to China in 2000. He was hired to be chief physician of Internal Medicine Department, second level professor, PhD advisor and chief expert of Oncology Medicine at Sun Yat-Sen University Cancer Center. He served as Chief of Medicine, Chief of Lynphoma Center, Vice President of Cancer Center, and director of the Academic Committee of the National Anti-Cancer New Drug Clinical Trial Center. He also worked as first dean of Shenzhen University Medical School and CEO of its affiliated hospital, and president of Boao Evergrande International Hospital (Brigham and Women's Hospital). From 2021, he began to serve as Deputy CMO and Chair of CoE in Oncology at Guangzhou R&F Hospital.

Prof. Jiang is taking the following academic positions: Vice president of Oncology Branch of Chinese Medical Doctor Association, executive director and deputy secretary-general of China Anti-Cancer Association, vice chairman of Hong Kong and Macao Anti-Cancer Association, chairman of Clinical Chemotherapy Professional Committee of China Anti-Cancer Association Cancer, chairman of the Lymphoma Professional Committee of China Anti-Cancer Association, chairman of the Oncology Professional Committee of Guangdong Medical Association, deputy chairman of Oncology Branch of Guangdong Clinical Medical Association, chairman of the Oncology Specialty Alliance of South China Medical Association, etc. He is also an associate editor of "Journal of International Oncology" and "Chinese Journal of Clinical Oncology", editorial board member of "Lancet" and "Journal of Clinical Oncology" (Chinese edition).

Prof. Jiang has presided over the "New Anti-Cancer Drug Research Platform" project under the National Key Research Program. He is the editor-in-chief of several monographs such as "Clinical Oncology", "Lymphoma Diagnosis and Therapeutics" and "Oncology Biotherapy". He is a member of the clinical diagnosis and treatment expert team appointed by the Ministry of Health (Oncology). He has won honorary titles including "Famous Oncologist in China", "Sun Yat-Sen University Famous Doctor", "South China Famous Doctor" etc. He was member of the Standing Committee of Guangdong Provincial Committee of Chinese People’s Political Consultative Conference for two sessions.

Dr. Yi graduated from Guangzhou Medical University as Bachelor of Medical Science in 1990, then graduated from Sun Yat-Sen University as Doctor of Oncology in 2006. She has been a medical oncologist for over 30 years, with focus on diagnosis and integrated treatment of common malignant tumors, especially chemotherapy, targeted therapy and immunotherapy for lung cancer, breast cancer, lymphoma, gastric cancer and colon cancer. She also has extensive clinical experience in recovery of bone marrow functions and body resistance after chemotherapy, as well as in palliative care for terminal cancer patients (cancer pain, anemia, nutritional support, etc.).

Dr. Yi practiced in Department of Medical Oncology at Second Affiliated Hospital of Guangzhou Medical University for over 10 years. In 2006, she started to serve at Guangzhou Red Cross Hospital as Director of Medical Oncology Department and established the Department of Oncology, which has won a series of awards such as  "Cancer Pain Standardized Treatment Demonstration Ward", "Standardized Management Ward of Chemotherapy-Related Vomiting (CINV)", and" Guangdong Hospital's Strongest Department Recommendation", and qualificaions including "First-Batch GI Tumor MDT Trial Hospital" and "National Drug Clinical Trial Qualification". She herself has presided over multiple provicial and municipal-level research, and has won the honorary title "Good Doctor in Guangzhou".

Honorary Titles:

Executive Director of Guangzhou Anti-Cancer Association

Executive Director of Guangdong Southern Cancer Clinical Research Association (CSWOG)

Member of Rare Tumor Expert Committee of Chinese Society of Clinical Oncology (CSCO)

Member of Oncology Branch of Guangdong Medical Association

Chairman of the First Lymphoma Committee of Guangzhou Anti Cancer Association

Vice Chairman of Liver, Gallbladder and Pancreas Committee of Guangzhou Anti Cancer Association

Standing Member of Lymphoma Committee of Guangdong Anti Cancer Association

Member of Cancer Chemotherapy Committee of Guangdong Anti Cancer Association

Standing Member of Digestive Tumor Committee of Guangdong Women Doctors Association

Member of Lung Cancer Committee of Guangdong Women Doctors Association

Member of Lymphoma Branch of Guangdong Precision Medicine Application Society

Dr. Liu graduated from Yanbian University. Prior to joining us, he served at Peking University Shoughang Hospital and Hebei Yizhou Cancer Hospital (Chinese PLA General Hospital International Proton Treatment Center). In his nearly 20 years of practice in Oncology, he specializes in diagnosis and treatment of common carcinomas, with great expertise in endocrine therapy and targeted therapy for malignant breast tumor, chemotherapy, targeted therapy, and combined targeted therapy and immunotherapy for lung cancer, as well as combination immunotherapy for digestive system tumors. Dr. Liu's expertise also includes combining chemotherapy and targeted therapy for malignant serous effusion to achieve satisfactory clinical outcome, and applying TCM-western integrative medicine to advanced cancer patients to improve both their survival period and quality of living. He is also familiar with the advanced radiotherapies such as PROTON and TOMO, etc. 

Academic Titles: Member of Beijing Association of Oncology; Member of Beijing TCM Association of Oncology; Member of Chongqing Youth Association of Oncology

Dr. Xu graduated from University of South China with a Master's degree in Oncology under the mentorship of Professor Luo Yi from Hunan Cancer Hospital. From 2015 to 2018, he completed his residency training program at the Second Xiangya Hospital of Central South University and Hunan Cancer Hospital. Since graduation, Dr Xu has been actively practicing in clinical oncology. His experience focuses on chemotherapy, immunotherapy and targeted therapy for common solid tumors, with expertise on resuscitation and palliative care.

Academic titles:

Member, Tumor Microenvironment Committee, China Anti-Cancer Association

Member, Lung Cancer Committee, Guangzhou Anti-Cancer Association

Dr. Liu graduated with a Master's degree in Oncology from Wuhan University in 2010. As an active oncologist with over ten years of experience, Dr. Liu has accumulated not only insights into common internal medicine diseases, but also expertise on carcinomas such as lung cancer, colorectal cancer, nasopharyngeal cancer, breast cancer, etc. Before joining us, she served in the Clinical Oncology Center at University of Hong Kong-Shenzhen Hospital from 2015, then in the Internal Medicine Department at Peking University Shenzhen Hospital from 2020.